Clinical significance of Hepatitis C Virus infection among end-stage kidney diseases receiving renal replacement therapy

Project no.: HIV-NAT 243/HCV dialysis study

Brief summary: This study is a multicenter, cross sectional study that will assess the prevalence of active HCV in patients with end stage kidney disease on long-term renal replacement therapy.